RHEP Form 3 Filed: Director Gene Burleson Reports No Direct Shares

Rhea-AI Filing Summary

Gene E. Burleson, a director of Regional Health Properties, Inc. filed an initial Form 3 disclosing beneficial ownership under Section 16. The form records the triggering event date as 08/14/2025 and a signed filing date of 08/18/2025. The filing shows 0 shares of common stock beneficially owned and indicates the report was filed by one reporting person from an Atlanta, GA address.

Positive

• Form 3 was filed showing compliance with Section 16 reporting requirements
• Signed filing date is recorded as 08/18/2025, shortly after the event date

Negative

• Zero common shares reported, indicating no direct equity stake disclosed
• No derivative or indirect ownership reported to indicate other forms of exposure

Insights

Corporate Governance Analyst

Director filed a timely initial ownership report showing no direct common shares.

The filing documents an initial Section 16 report from Gene E. Burleson with an event date of 08/14/2025 and a signature date of 08/18/2025, indicating compliance with short-form insider reporting timelines.

This disclosure shows 0 common shares held directly, which means there is no disclosed equity alignment from direct share ownership; investors and governance observers may note this when assessing insider alignment in the near term.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BURLESON GENE E

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 0 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 08/18/2025 - 08:30 PM Learn about SEC filing dates

FAQ

What did Gene E. Burleson disclose on the Form 3 for RHE?

The Form 3 shows 0 shares of common stock beneficially owned and records the event date 08/14/2025 with a signature date of 08/18/2025.

Does the filing show any derivative or indirect ownership for the director?

No. Table II and the nature of indirect beneficial ownership fields show no derivative or indirect ownership disclosed.

Was the Form 3 filed by more than one reporting person?

No. The form indicates it was filed by one reporting person.

What role does the reporting person hold at Regional Health Properties?

The reporting person is listed as a Director of Regional Health Properties, Inc.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BURLESON GENE E

(Last) (First) (Middle)

C/O REGIONAL HEALTH PROPERTIES, INC.

1050 CROWN POINTE PARKWAY, SUITE 720

(Street)

ATLANTA GA 30338

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/14/2025

3. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gene E. Burleson	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.